...
【24h】

Influence of pH modifiers on the dissolution and stability of hydrochlorothiazide in the bi- and three-layer tablets

机译:pH调节剂对氢氯噻嗪在双层和三层片剂中的溶解和稳定性的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

During the past few years, the studies of bi- and multi-layered tablets increased due to the consumption of several different drugs per day by a patient and requests for appropriate patient compliance. The demographic shift toward older population increases the use of combination therapy as polypharmacy. Hydrochlorothiazide (HCTZ), as a model drug, is most commonly used in the treatment of hypertension, congestive heart failure and as a diuretic. The aim of the present study is to investigate the effect of the local environment on dissolution and stability behaviour of HCTZ in fixed multilayered tablet combinations, which are commonly used in polypharmacy. For this purposes, three different systems were introduced: (i) two conventional tablets (HCTZ and pH modifying placebo), (ii) 2-layer tablets (HCTZ, pH modifying placebo) and (iii) 3-layer tablets (HCTZ, barrier and pH modifying placebo). Disintegration of tablets, dissolution of HCTZ from tablets and HCTZ related substances were monitored for all systems. Results showed that there was a significant difference between dissolution profiles of the conventional two-tablet system (HCTZ tablet and pH modifying tablet) and the 2-layer and 3-layer tablets, which include the pH modifying layer. In the case of the conventional two-tablets system, 85 % of HCTZ was dissolved in less than 15 minutes. The dissolution profiles of HCTZ from 2-layered and 3-layered tablets showed a decrease in the dissolution rate. In addition, during the stability studies, it has been confirmed that the typical degradation product of HCTZ is formed, impurity B (4-amino-6-chloro-1,3-benzenedisulfonamide), which implies formation of formaldehyde as hydrolytic impurity not reported in the Ph. Eur. (16). Both impurities are particularly raised in 2-layered tablets with alkaline and neutral placebo layers. Stability of HCTZ was improved in the case of the 3-layer tablet, where the intermediate separation layer of glycerol monostearate was present. It is presumed that the HCTZ dissolution rate was decreased due to formation of non-soluble substances as a result of HCTZ degradation in the presence of alkaline layer.
机译:在过去的几年中,由于患者每天消耗几种不同的药物并要求适当的患者依从性,因此对双层和多层片剂的研究有所增加。人口向老年人口的转移增加了联合疗法作为多元药房的使用。氢氯噻嗪(HCTZ)作为模型药物,最常用于治疗高血压,充血性心力衰竭和利尿剂。本研究的目的是研究固定化多层片剂组合中HCTZ的溶解和稳定性行为对局部环境的影响。为此,引入了三种不同的系统:(i)两种常规片剂(HCTZ和pH调节安慰剂),(ii)2层片剂(HCTZ,pH调节安慰剂)和(iii)3层片剂(HCTZ,阻隔剂和pH调节安慰剂)。监测所有系统的片剂崩解,HCTZ从片剂中的溶解以及与HCTZ相关的物质。结果表明,常规两片片剂系统(HCTZ片剂和pH调节片剂)与2层和3层片剂(包括pH调节层)的溶出曲线之间存在显着差异。在传统的两片片剂系统中,不到15分钟即可溶解85%的HCTZ。 HCTZ从2层和3层片剂中的溶出曲线显示溶出速率降低。此外,在稳定性研究过程中,已确认形成了HCTZ的典型降解产物,即杂质B(4-氨基-6-氯-1,3-苯二磺酰胺),这暗示未形成甲醛作为水解杂质。在欧洲博士。 (16)。两种杂质在带有碱性和中性安慰剂层的2层片剂中都会特别升高。在三层片剂的情况下,HCTZ的稳定性得到改善,其中存在甘油单硬脂酸酯的中间分离层。据推测,由于存在碱性层时HCTZ降解,由于形成不溶性物质而降低了HCTZ的溶解速率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号